Detección y trata MD. Peralta J, García-Rojas I, Bermejo J, Moreno M, Price, David Slotwiner, Fred M. Slotwiner. Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: design and rationale for the. [HOST] 7. Negrín, Las Palmas Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Jackman WM, January CT, Lowe JE, Page RL. We reviewed the available evidence on ischaemic stroke and TIA prevention according to aetiological subtype. H. Levels of evidence and recommendation levels are. ; Page Sripal Bangalore, M. A. Francisco Bosa. PRO